Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Research

Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

Cite this Article

To cite this article please use the text below.

Colombo Bonadio Renata, Isaacsson Velho Pedro, Nader Marta Guilherme, Nardo Mirella, Souza Manoel Carlos LA, Muniz David QB, Bezerra Regis OF, Bispo Raisa KA, Faraj Sheila F, Bastos Diogo A and Dzik Carlos (2019) Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable? ecancer 13 973



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation